NCT03280797View on ClinicalTrials.gov

Feasibility of a Cytokine Expression Profile in Immune Cells as an Orientation Tool in Therapeutic Decisions for Auto-inflammatory and Auto-immune Diseases

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

November 24, 2017

Primary Completion Date

February 8, 2021

Study Completion Date

January 12, 2022

Conditions
Rheumatoid Arthritis
Interventions
PROCEDURE

Blood sample

2ml blood taken into TruCulture tube

Trial Locations (2)

30029

CHU Nimes, Nîmes

34295

CHU de Montpellier, Montpellier

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT03280797 - Feasibility of a Cytokine Expression Profile in Immune Cells as an Orientation Tool in Therapeutic Decisions for Auto-inflammatory and Auto-immune Diseases | Biotech Hunter | Biotech Hunter